Bottom line of study: SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney ...

Initially used for blood glucose control, the medications reduce cardiovascular events and mitigate heart failure ...

For people with advanced heart failure, left ventricular assist devices, or LVADs, can be a literal lifesaver.

Experts say that semaglutide and tirzepatide can help patients with heart failure lose weight, but limited NHS access is ...

SGLT2 inhibitors have become a major drug used to treat diabetes, heart failure, and chronic kidney disease. However, there ...

A Cardiff-based business working on "revolutionary" new pacemaker technology, aimed at helping patients with long-term heart ...

The FDA has approved a new pill called Widaplik, which combines three drugs – telmisartan, amlodipine, and indapamide – to treat adults who have high blood pressure.

Find Treatment Targets Latest News, Videos & Pictures on Treatment Targets and see latest updates, news, information from NDTV.COM. Explore more on Treatment Targets.

Mesoblast shares jumped after the biotechnology group reported "continued momentum" with the US Food and Drug Administration ...

Maury Regional Health (MRH) is now offering an advanced tool for patients with heart failure: the CardioMEMS™ HF System. This ...

Despite incomplete evidence, longevity enthusiasts are experimenting with SGLT2 inhibitors in their quest to live healthier ...